Sumaiya Iqbal, PhD

The Center for Development of Therapeutics, Broad Institute of MIT and Harvard, Massachusetts, United States

Sumaiya Iqbal is the group leader of the bioinformatics and computational biology group within the Center for the Development of Therapeutics (CDoT) at the Broad Institute of MIT and Harvard. She is a computer scientist by training but a life science researcher by determination; she uses data science and machine learning to bridge genetics, proteomics, and therapeutics. The focus of her group is twofold: develop AI-driven innovative technology for small-molecule hit identification using data from DNA-encoded library screening, HTS, etc., and drug target analysis by rationalizing functional consequences of genetic variants on protein structure and function. Toward linking genetic screening outputs to protein sequence and structure for the full human proteome, she developed the discovery tool called Genomics to Proteins portal (https://g2p.broadinstitute.org/).

Contact Sumaiya Iqbal via email at sumaiya@broadinstitute.org.

Disclosure information not submitted.

Presentation(s):

• DEL+ML paradigm for discovering actionable hits – a comparative analysis of three diverse DNA-encoded libraries (DEL) and multiple machine learning (ML) algorithms

  Monday, February 5, 2024
  3:30 PM – 4:00 PM EST